Subsequent investigations revealed that tumors with MET amplification displayed reduced levels of STING and less infiltration of CTLs and NK cells, and decreased tumor immunogenicity of the MET-amplified tumor microenvironment was confirmed by single-cell RNA sequencing. Here, STING1 is linked to neoplasm.